Morgan Joseph Downgrades Genzyme (GENZ) to Hold; To be Acquired for $74 Plus CVRs
Tweet Send to a Friend
Morgan Joseph downgraded Genzyme (NASDAQ: GENZ) from Buy to Hold.
Morgan analyst says, "It was announced yesterday that an agreement ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan analyst says, "It was announced yesterday that an agreement ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
